QQQ   423.41 (-0.57%)
AAPL   167.04 (-0.57%)
MSFT   404.27 (-1.84%)
META   501.80 (+1.54%)
GOOGL   156.01 (+0.35%)
AMZN   179.22 (-1.14%)
TSLA   149.93 (-3.55%)
NVDA   846.71 (+0.76%)
AMD   155.08 (+0.69%)
NIO   4.00 (+2.30%)
BABA   68.88 (+0.09%)
T   16.33 (+1.30%)
F   12.06 (+0.17%)
MU   111.93 (-3.78%)
GE   152.94 (-1.75%)
CGC   7.83 (+20.65%)
DIS   112.43 (-0.45%)
AMC   2.92 (-2.01%)
PFE   25.39 (-0.12%)
PYPL   62.10 (-1.83%)
XOM   118.52 (-0.09%)
QQQ   423.41 (-0.57%)
AAPL   167.04 (-0.57%)
MSFT   404.27 (-1.84%)
META   501.80 (+1.54%)
GOOGL   156.01 (+0.35%)
AMZN   179.22 (-1.14%)
TSLA   149.93 (-3.55%)
NVDA   846.71 (+0.76%)
AMD   155.08 (+0.69%)
NIO   4.00 (+2.30%)
BABA   68.88 (+0.09%)
T   16.33 (+1.30%)
F   12.06 (+0.17%)
MU   111.93 (-3.78%)
GE   152.94 (-1.75%)
CGC   7.83 (+20.65%)
DIS   112.43 (-0.45%)
AMC   2.92 (-2.01%)
PFE   25.39 (-0.12%)
PYPL   62.10 (-1.83%)
XOM   118.52 (-0.09%)
QQQ   423.41 (-0.57%)
AAPL   167.04 (-0.57%)
MSFT   404.27 (-1.84%)
META   501.80 (+1.54%)
GOOGL   156.01 (+0.35%)
AMZN   179.22 (-1.14%)
TSLA   149.93 (-3.55%)
NVDA   846.71 (+0.76%)
AMD   155.08 (+0.69%)
NIO   4.00 (+2.30%)
BABA   68.88 (+0.09%)
T   16.33 (+1.30%)
F   12.06 (+0.17%)
MU   111.93 (-3.78%)
GE   152.94 (-1.75%)
CGC   7.83 (+20.65%)
DIS   112.43 (-0.45%)
AMC   2.92 (-2.01%)
PFE   25.39 (-0.12%)
PYPL   62.10 (-1.83%)
XOM   118.52 (-0.09%)
QQQ   423.41 (-0.57%)
AAPL   167.04 (-0.57%)
MSFT   404.27 (-1.84%)
META   501.80 (+1.54%)
GOOGL   156.01 (+0.35%)
AMZN   179.22 (-1.14%)
TSLA   149.93 (-3.55%)
NVDA   846.71 (+0.76%)
AMD   155.08 (+0.69%)
NIO   4.00 (+2.30%)
BABA   68.88 (+0.09%)
T   16.33 (+1.30%)
F   12.06 (+0.17%)
MU   111.93 (-3.78%)
GE   152.94 (-1.75%)
CGC   7.83 (+20.65%)
DIS   112.43 (-0.45%)
AMC   2.92 (-2.01%)
PFE   25.39 (-0.12%)
PYPL   62.10 (-1.83%)
XOM   118.52 (-0.09%)

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
$0.48
+0.3%
$0.43
$0.32
$0.75
$23.80M-0.1213,883 shs176,741 shs
Cabelas Inc stock logo
CAB
Cabelas
$0.05
$0.00
$45.00
$63.60
N/AN/A921,921 shsN/A
ClearBridge MLP and Midstream Total Return Fund Inc. stock logo
CTR
ClearBridge MLP and Midstream Total Return Fund
$40.08
+0.5%
$39.76
$27.47
$42.61
N/AN/A14,066 shs11,265 shs
Eaton Vance Senior Floating-Rate Trust stock logo
EFR
Eaton Vance Senior Floating-Rate Trust
$13.09
-0.2%
$13.03
$10.95
$13.28
N/AN/A92,960 shs100,501 shs
SPDR S&P Dividend ETF stock logo
SDY
SPDR S&P Dividend ETF
$125.65
+0.5%
$127.01
$109.87
$131.67
$19.98B0.73392,962 shs238,835 shs
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
-4.69%-14.75%+22.29%+9.61%-8.52%
Cabelas Inc stock logo
CAB
Cabelas
0.00%0.00%0.00%0.00%0.00%
ClearBridge MLP and Midstream Total Return Fund Inc. stock logo
CTR
ClearBridge MLP and Midstream Total Return Fund
+0.87%-4.02%+0.05%+13.51%+30.01%
Eaton Vance Senior Floating-Rate Trust stock logo
EFR
Eaton Vance Senior Floating-Rate Trust
+0.23%-0.15%+0.38%+2.50%+13.80%
SPDR S&P Dividend ETF stock logo
SDY
SPDR S&P Dividend ETF
+0.32%-2.26%-1.99%+1.73%+0.76%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
N/AN/AN/AN/AN/AN/AN/AN/A
Cabelas Inc stock logo
CAB
Cabelas
N/AN/AN/AN/AN/AN/AN/AN/A
ClearBridge MLP and Midstream Total Return Fund Inc. stock logo
CTR
ClearBridge MLP and Midstream Total Return Fund
N/AN/AN/AN/AN/AN/AN/AN/A
Eaton Vance Senior Floating-Rate Trust stock logo
EFR
Eaton Vance Senior Floating-Rate Trust
N/AN/AN/AN/AN/AN/AN/AN/A
SPDR S&P Dividend ETF stock logo
SDY
SPDR S&P Dividend ETF
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
N/AN/AN/AN/A
Cabelas Inc stock logo
CAB
Cabelas
N/AN/AN/AN/A
ClearBridge MLP and Midstream Total Return Fund Inc. stock logo
CTR
ClearBridge MLP and Midstream Total Return Fund
N/AN/AN/AN/A
Eaton Vance Senior Floating-Rate Trust stock logo
EFR
Eaton Vance Senior Floating-Rate Trust
N/AN/AN/AN/A
SPDR S&P Dividend ETF stock logo
SDY
SPDR S&P Dividend ETF
0.00
N/A$137.129.13% Upside

Current Analyst Ratings

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
$200K118.99N/AN/A$0.20 per share2.38
Cabelas Inc stock logo
CAB
Cabelas
N/AN/AN/AN/AN/AN/A
ClearBridge MLP and Midstream Total Return Fund Inc. stock logo
CTR
ClearBridge MLP and Midstream Total Return Fund
$42.57MN/AN/AN/AN/AN/A
Eaton Vance Senior Floating-Rate Trust stock logo
EFR
Eaton Vance Senior Floating-Rate Trust
$55.66MN/AN/AN/AN/AN/A
SPDR S&P Dividend ETF stock logo
SDY
SPDR S&P Dividend ETF
N/AN/AN/AN/AN/AN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
-$28.96M-$0.60N/AN/A-14,337.62%-121.69%-97.91%5/13/2024 (Estimated)
Cabelas Inc stock logo
CAB
Cabelas
N/AN/A0.00N/AN/AN/AN/AN/A
ClearBridge MLP and Midstream Total Return Fund Inc. stock logo
CTR
ClearBridge MLP and Midstream Total Return Fund
N/A$1.3629.47N/AN/AN/AN/AN/A
Eaton Vance Senior Floating-Rate Trust stock logo
EFR
Eaton Vance Senior Floating-Rate Trust
N/AN/A0.00N/AN/AN/AN/AN/A
SPDR S&P Dividend ETF stock logo
SDY
SPDR S&P Dividend ETF
N/AN/A19.41N/AN/AN/AN/AN/A

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
N/AN/AN/AN/AN/A
Cabelas Inc stock logo
CAB
Cabelas
N/AN/AN/AN/AN/A
ClearBridge MLP and Midstream Total Return Fund Inc. stock logo
CTR
ClearBridge MLP and Midstream Total Return Fund
$2.666.64%+2.96%195.59%3 Years
Eaton Vance Senior Floating-Rate Trust stock logo
EFR
Eaton Vance Senior Floating-Rate Trust
$1.3710.47%+17.33%N/A1 Years
SPDR S&P Dividend ETF stock logo
SDY
SPDR S&P Dividend ETF
$3.202.55%N/AN/AN/A

Latest CTR, EFR, AIM, CAB, and SDY Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/1/2024
Eaton Vance Senior Floating-Rate Trust stock logo
EFR
Eaton Vance Senior Floating-Rate Trust
Monthly$0.121011.28%4/22/20244/23/20244/30/2024
3/1/2024
Eaton Vance Senior Floating-Rate Trust stock logo
EFR
Eaton Vance Senior Floating-Rate Trust
monthly$0.121010.2%3/20/20243/21/20243/28/2024
1/19/2024
ClearBridge MLP and Midstream Total Return Fund Inc. stock logo
CTR
ClearBridge MLP and Midstream Total Return Fund
quarterly$0.707.9%2/21/20242/22/20242/29/2024
2/1/2024
Eaton Vance Senior Floating-Rate Trust stock logo
EFR
Eaton Vance Senior Floating-Rate Trust
monthly$0.121010%2/21/20242/22/20242/29/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
N/A
1.68
1.68
Cabelas Inc stock logo
CAB
Cabelas
N/AN/AN/A
ClearBridge MLP and Midstream Total Return Fund Inc. stock logo
CTR
ClearBridge MLP and Midstream Total Return Fund
N/AN/AN/A
Eaton Vance Senior Floating-Rate Trust stock logo
EFR
Eaton Vance Senior Floating-Rate Trust
N/AN/AN/A
SPDR S&P Dividend ETF stock logo
SDY
SPDR S&P Dividend ETF
N/AN/AN/A

Ownership

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
2249.90 million49.89 millionNot Optionable
Cabelas Inc stock logo
CAB
Cabelas
N/AN/AN/AOptionable
ClearBridge MLP and Midstream Total Return Fund Inc. stock logo
CTR
ClearBridge MLP and Midstream Total Return Fund
N/AN/AN/ANot Optionable
Eaton Vance Senior Floating-Rate Trust stock logo
EFR
Eaton Vance Senior Floating-Rate Trust
N/AN/AN/ANot Optionable
SPDR S&P Dividend ETF stock logo
SDY
SPDR S&P Dividend ETF
N/A159.05 millionN/ANot Optionable

CTR, EFR, AIM, CAB, and SDY Headlines

SourceHeadline
5 Dividend ETFs to Buy as Market Volatility Rises5 Dividend ETFs to Buy as Market Volatility Rises
zacks.com - April 18 at 11:06 AM
SPDG: A Newer Dividend-Focused ETF Worth Some AttentionSPDG: A Newer Dividend-Focused ETF Worth Some Attention
seekingalpha.com - April 8 at 5:32 AM
SPDR Nuveen S&P High Yield Municipal Bond ETF declares monthly distribution of $0.0890SPDR Nuveen S&P High Yield Municipal Bond ETF declares monthly distribution of $0.0890
msn.com - April 1 at 1:51 PM
5 Good ETFs to Buy & Hold For Years5 Good ETFs to Buy & Hold For Years
zacks.com - March 28 at 8:36 AM
Should SPDR S&P Dividend ETF (SDY) Be on Your Investing Radar?Should SPDR S&P Dividend ETF (SDY) Be on Your Investing Radar?
zacks.com - March 18 at 7:21 AM
Is SPDR S&P Dividend ETF (SDY) a Strong ETF Right Now?Is SPDR S&P Dividend ETF (SDY) a Strong ETF Right Now?
zacks.com - March 15 at 7:21 AM
Dividend ETFs to Consider Amid Hot Inflation DataDividend ETFs to Consider Amid Hot Inflation Data
zacks.com - March 13 at 11:21 AM
Are Dividend Growth Funds Ready for Liftoff?Are Dividend Growth Funds Ready for Liftoff?
etftrends.com - March 12 at 5:06 PM
Kimberly-Clark a Top Ranked SAFE Dividend Stock With 3.9% Yield (KMB)Kimberly-Clark a Top Ranked SAFE Dividend Stock With 3.9% Yield (KMB)
nasdaq.com - March 9 at 11:57 PM
Ampol Declares Special Dividend as Underlying Profit Improves -- UpdateAmpol Declares Special Dividend as Underlying Profit Improves -- Update
marketwatch.com - February 18 at 8:07 PM
5 ETFs to Love Forever5 ETFs to Love Forever
msn.com - February 14 at 2:26 PM
5 ETFs to Love Forever5 ETFs to Love Forever
zacks.com - February 14 at 2:01 PM
Best Dividend ETFs to Buy NowBest Dividend ETFs to Buy Now
kiplinger.com - February 14 at 11:14 AM
5 High-Dividend ETFs Available Under $70 to Play Now5 High-Dividend ETFs Available Under $70 to Play Now
msn.com - February 9 at 2:32 PM
3 ETF Investment Mistakes to Avoid3 ETF Investment Mistakes to Avoid
morningstar.com - January 24 at 12:35 AM
SPDR S&P 500 UCITS ETF USD Acc (SPYL)SPDR S&P 500 UCITS ETF USD Acc (SPYL)
investing.com - January 3 at 12:28 PM
SDY: High Yield Dividend Aristocrats May Continue To StagnateSDY: High Yield Dividend Aristocrats May Continue To Stagnate
seekingalpha.com - December 6 at 3:58 PM
2 Dividend Aristocrats To Avoid2 Dividend Aristocrats To Avoid
seekingalpha.com - December 4 at 7:00 AM
Beaten-up investors put more than $60bn in a group of funds meant for stormy markets—but just a few months later the trade is misfiringBeaten-up investors put more than $60bn in a group of funds meant for stormy markets—but just a few months later the trade is misfiring
fortune.com - November 27 at 9:28 AM
A New Dividend-Growth ETF (TBG) Hits the MarketA New Dividend-Growth ETF (TBG) Hits the Market
finance.yahoo.com - November 16 at 7:14 PM
SDY: Is State Streets Dividend ETF A Strong Income Vehicle?SDY: Is State Street's Dividend ETF A Strong Income Vehicle?
seekingalpha.com - November 16 at 2:09 PM
SPLG: The Market’s Lowest-Cost S&P 500 ETFSPLG: The Market’s Lowest-Cost S&P 500 ETF
markets.businessinsider.com - August 29 at 9:37 PM
My Top 15 High Growth Dividend Stocks For August 2023My Top 15 High Growth Dividend Stocks For August 2023
msn.com - August 5 at 11:34 PM
Quality ETFs to Shine in Second Half of 2023?Quality ETFs to Shine in Second Half of 2023?
uk.finance.yahoo.com - July 13 at 12:27 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

AIM ImmunoTech logo

AIM ImmunoTech

NYSE:AIM
AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's lead product candidate is Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome (CFS). It is also developing Ampligen for the treatment of renal cell carcinoma, malignant melanoma, non-small cell lung, ovarian, breast, colorectal, prostate and pancreatic cancer, myalgic encephalomyelitis, Hepatitis B, HIV, COVID-19, and post-COVID conditions. In addition, the company provides Alferon N Injection, an injectable formulation of natural alpha interferon to treat human papilloma viruses, and genital warts, a sexually transmitted disease. AIM ImmunoTech Inc. has agreements with Amarex Clinical Research LLC; Pharmaceutics International Inc.; Polysciences Inc.; and University of Cagliari Dipartimento di Scienze della Vita e dell'Ambiente. The company was formerly known as Hemispherx Biopharma, Inc. and changed its name to AIM ImmunoTech Inc. in August 2019. AIM ImmunoTech Inc. was incorporated in 1966 and is headquartered in Ocala, Florida.
Cabelas logo

Cabelas

NYSE:CAB
Cabela's Incorporated is an omni-channel retailer of hunting, fishing, camping, shooting sports and related outdoor merchandise. The Company offers its customers a selection of national and regional brand products, including its Cabela's brand. The Company's segments include Merchandising and Financial Services. The Merchandising segment sells products and services through the Company's retail stores, its e-commerce Websites (Cabelas.com and Cabelas.ca), and its catalogs. The United States merchandising and Canada merchandising operating segments have been aggregated into its Merchandising segment. The Financial Services segment issues co-branded credit cards, which are available through all of its channels. The Company's product assortment includes merchandise and equipment for hunting, fishing, marine use, camping, and recreational sport shooting, along with casual and outdoor apparel and footwear, optics, vehicle accessories, and gifts and home furnishings with an outdoor theme.
ClearBridge MLP and Midstream Total Return Fund logo

ClearBridge MLP and Midstream Total Return Fund

NYSE:CTR
ClearBridge MLP and Midstream Total Return Fund Inc. is an open ended equity mutual fund of funds launched and managed by Legg Mason Partners Fund Advisor, LLC. The fund is co-managed by ClearBridge Investments, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the energy sector. It primarily invests in equity securities of MLPs, stocks of entities holding primarily general partner or managing member interests in MLPs, and securities that are derivatives of interests in MLPs such as exchange traded funds. ClearBridge MLP and Midstream Total Return Fund Inc. was formed on April 10, 2012 and is domiciled in the United States.
Eaton Vance Senior Floating-Rate Trust logo

Eaton Vance Senior Floating-Rate Trust

NYSE:EFR
Eaton Vance Senior Floating-Rate Trust is a closed-ended fixed income mutual fund launched and managed by Eaton Vance Management. The fund invests in the fixed income markets of the United States. It primarily invests in senior, secured floating rate loans. It benchmarks the performance of its portfolio against the S&P/LSTA Leveraged Loan Index. Eaton Vance Senior Floating-Rate Trust was formed on November 28, 2003 and is domiciled in the United States.
SPDR S&P Dividend ETF logo

SPDR S&P Dividend ETF

NYSEARCA:SDY
The SPDR S&P Dividend ETF seeks to closely match the returns and characteristics of the S&P High Yield Dividend Aristocrats Index (the Index). The Index is designed to measure the performance of the 60 highest dividend yielding S&P Composite 1500 Index constituents that have followed a managed-dividends policy of consistently increasing dividends every year for at least 25 consecutive years. The Fund generally invests substantially all, but at least 80%, of its total assets in the securities comprising the Index. In addition, the Fund may invest in equity securities that are not included in the Index, cash and cash equivalents or money market instruments, such as repurchase agreements and money market funds (including money market funds advised by the Adviser). SSgA Funds Management, Inc. is the investment adviser to the Fund.